α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls.
α-synuclein is thought to play a key role in Parkinson's disease (PD) because it is the major protein in Lewy bodies, and because its gene mutations, duplication, and triplication are associated with early-onset PD. There are conflicting reports as to whether serum and plasma concentrations of...
Main Authors: | Lynnae M Smith, Mya C Schiess, Mary P Coffey, Andrea C Klaver, David A Loeffler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3524108?pdf=render |
Similar Items
-
Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms
by: Mario Meloni, et al.
Published: (2023-01-01) -
Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study
by: Kari Anne Bjørnarå, et al.
Published: (2018-02-01) -
α-Synuclein and dopamine at the crossroads of Parkinson's disease.
by: Venda, L, et al.
Published: (2010) -
The Role of α-Synuclein Oligomers in Parkinson’s Disease
by: Xiao-yu Du, et al.
Published: (2020-11-01) -
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
by: Tingting Du, et al.
Published: (2021-03-01)